Janet Tu - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Janet Tu's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Janet Tu
Verified
Assistant Features Editor, The Seattle Times
Seattle
Beats
Sports, Current Events Human and Animal Rights,Humor Bios, Food & Travel etc., Mexico Finance, Lifestyle
Content
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy - Nature Communications
By Sang T. Kim, Sattva Neelapu, Amishi Y. Shah, Matthew Campbell, don gibbons, Tina Cascone, Janet Tu Verified, Shannon N. Westin, Aung Naing, Guillermo Garcia-Manero, Hussein Tawbi, michael davies, Sapna P. Patel, Jun Zou, Andrew Futreal, Linghua Wang| Nature Verified Correction to: Nature Communications https://doi.org/10.1038/s41467-022-29539-3, published online 12 April 2022In this article the funding information for Jordan Kramer was omitted and should have read, ‘J.K. is supported by the CPRIT Research Training Award CPRIT Training Program (RP210028)’. The original article has been corrected.
By Janet Tu Verified| brnw.ch@ Many cancer patients ask how long it might take for chemotherapy to shrink their tumors. That’s a tough question because the answer depends on so many variables. We have to consider the type of cancer, as well as its stage, size and location. The type of chemotherapy drug(s) we’re giving the patient also plays a role, along with any other kinds of therapy they’re receiving. The most important factor, though, is the biology of the cancer itself.
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy - Nature Communications
By Sang T. Kim, Sattva Neelapu, Amishi Y. Shah, Matthew Campbell, don gibbons, Tina Cascone, Janet Tu Verified, Shannon N. Westin, Aung Naing, Guillermo Garcia-Manero, Hussein Tawbi, michael davies, Sapna P. Patel, Jun Zou, Andrew Futreal, Linghua Wang| Nature Verified Correction to: Nature Communications https://doi.org/10.1038/s41467-022-29539-3, published online 12 April 2022In this article the funding information for Jordan Kramer was omitted and should have read, ‘J.K. is supported by the CPRIT Research Training Award CPRIT Training Program (RP210028)’. The original article has been corrected.
Company Info
The Seattle Times
The Seattle Times is a prominent newspaper based in the Pacific Northwest, founded in 1891. Originally known as the Seattle Press-Times, it evolved through several name changes before becoming The Seattle Times in 1966. It is one of the few major city dailies in the U.S. that remains independently operated and owned by a local family, the Blethens. The Seattle Times offers a daily newspaper that covers local, national, and international news, along with a robust digital platform that is among the most visited news sites in the region. The newspaper has a rich history of documenting significant events in Seattle, including the Klondike Gold Rush. It has received numerous accolades, including 11 Pulitzer Prizes, highlighting its commitment to quality journalism. The Seattle Times serves a diverse audience, including residents and businesses in Seattle and surrounding areas, providing essential news and information to the community.
Seattle, Washington, United States
+1 206-464-2539
Founded: 1896